Multivariable analysis for patients aged 18 to 60 years in AP/CP2+ undergoing allo-HCT using MAC vs RIC for CML, 2007-2014
| . | n . | HR . | 95% CI . | P . |
|---|---|---|---|---|
| cGVHD | ||||
| MAC | 668 | 1 | ||
| RIC | 97 | 0.83 | 0.60-1.15 | .26 |
| Relapse ≤5 mo | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 2.06 | 1.31-3.23 | .002 |
| Relapse >5 mo | ||||
| MAC | 503 | 1 | ||
| RIC | 99 | 0.46 | 0.20-1.05 | .06 |
| NRM | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 1.32 | 0.89-1.94 | .17 |
| LFS | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 1.27 | 0.97-1.66 | .08 |
| OS | ||||
| MAC | 683 | 1 | ||
| RIC | 98 | 1.18 | 0.88-1.57 | .26 |
| . | n . | HR . | 95% CI . | P . |
|---|---|---|---|---|
| cGVHD | ||||
| MAC | 668 | 1 | ||
| RIC | 97 | 0.83 | 0.60-1.15 | .26 |
| Relapse ≤5 mo | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 2.06 | 1.31-3.23 | .002 |
| Relapse >5 mo | ||||
| MAC | 503 | 1 | ||
| RIC | 99 | 0.46 | 0.20-1.05 | .06 |
| NRM | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 1.32 | 0.89-1.94 | .17 |
| LFS | ||||
| MAC | 672 | 1 | ||
| RIC | 98 | 1.27 | 0.97-1.66 | .08 |
| OS | ||||
| MAC | 683 | 1 | ||
| RIC | 98 | 1.18 | 0.88-1.57 | .26 |